Instructions
for Authors
ONLINE MANUSCRIPT SUBMISSION:
An online submission and tracking service via Internet facilitates
a speedy and cost-effective submission of manuscripts. The
full manuscript has to be submitted online via Bentham's Content
Management System (CMS) at http://bsp-cms.eurekaselect.com/
View
Submission Instructions
Manuscripts must be submitted by one of the authors of the
manuscript, and should not be submitted by anyone on their
behalf. The principal/corresponding author will be required
to submit a Covering Letter along with the manuscript, on
behalf of all the co-authors (if any). The author(s) will
confirm that the manuscript (or any part of it) has not been
published previously or is not under consideration for publication
elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright
permission for reproduction must be obtained.
For all online submissions, please provide soft copies of
all the materials (main text in MS Word or Tex/LaTeX), figures
/ illustrations in TIFF, PDF or JPEG, and chemical structures
drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files,
while a PDF version of the entire manuscript must also be
included, embedded with all the figures / illustrations /
tables / chemical structures etc. It is advisable that the
document files related to a manuscript submission should always
have the name of the corresponding author as part of the file
name, i.e., “Cilli MS text.doc” , “Cilli
MS Figure 1”, etc.
It is imperative that before submission, authors should carefully
proofread the files for special characters, mathematical symbols,
Greek letters, equations, tables, references and images, to
ensure that they appear in proper format.
References, figures, tables, chemical structures etc.
should be referred to in the text at the appropriate place
where they are first discussed. Figure legends/captions should
also be provided.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author. Any queries therein should be addressed to samina@benthamscience.org
MANUSCRIPTS PUBLISHED: The Journal accepts
peer-reviewed mini- and full-length review articles and drug
clinical trial studies written in English. Single topic/thematic
issues may also be considered for publication.
Single Topic Issues: These peer reviewed
issues may contain invited review/mini-review articles. A
Single Topic Issue Editor will offer a short perspective and
co-ordinate the solicitation of manuscripts between 3-5 (for
a mini-hot topic) to 6-10 (for full-length hot topic) from
leading scientists. Authors interested in editing a single
topic issue in an emerging topic of drug discovery may submit
their proposal to the Editor-in-Chief at cbio@benthamscience.org
for consideration.
Conference Proceedings: For proposals to
publish conference proceedings in this journal, please contact
us at email: proceedings@benthamscience.org
MANUSCRIPT LENGTH:
Review Articles: The total number of words
for a published comprehensive review article article is from
8000 to 40000 words, and for mini-review articles from 3000
to 6000 words.
There is no restriction on the number of figures,
tables or additional files e.g. video clips, animation and
datasets, that can be included with each article online. Authors
should include all relevant supporting data with each article
(Refer to Supplementary Material section).
Drug Clinical Trial Studies: Drug clinical
trial studies are biomedical or health-related interventional
and/or observational research studies conducted in phases
in human beings that follow a pre-defined protocol.The study
is intended to find out whether promising approaches to the
disease prevention, diagnosis, and treatment are safe and
effective. The maximum total page length for a drug clinical
trial study published in the journal is four journal pages.
Each journal page is on average 900 words.
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct
and active style. All pages must be numbered sequentially,
facilitating in the reviewing and editing of the manuscript.
For further convenience, our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts
may be divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices
Figures/illustrations (if any)
Chemical structures (if any)
Tables (if any)
Supportive/supplementary material (if any)
Covering Letter: It is mandatory that a signed
covering letter also be submitted along with the
manuscript by the author to whom correspondence is to be addressed,
delineating the scope of the submitted article declaring the
potential competing interests, acknowledging contributions
from authors and funding agencies, and certifying that the
paper is prepared according to the 'Instructions
for Authors'. All inconsistencies in the
text and in the reference section, and any typographical errors
must be carefully checked and corrected before the submission
of the manuscript. The article contains no such material
or information that may be unlawful, defamatory, fabricated,
plagiarized, or which would, if published, in any way
whatsoever, violate the terms and conditions as laid down
in the copyright agreement. The authors acknowledge that
the publishers have the legal right to take appropriate action
against the authors for any such violation of the terms and
conditions as laid down in the copy right agreement. DOWNLOAD
COVERING LETTER
Title: The title of the article should be
precise and brief and must not be more than 120 characters.
Authors should avoid the use of non-standard abbreviations.
The title must be written in title case except for articles,
conjunctions and prepositions.
Authors should also provide a short ‘running title’.
Title, running title, byline, correspondent footnote and keywords
should be written as presented in original manuscripts.
Title Page: Title page should include paper
title, author(s) full name and affiliation, corresponding
author(s) names complete affiliation/address, along with phone,
fax and email.
Abstract: The abstract should not exceed
250 words for review papers and 150 words for drug clinical
trial studies summarizing the essential features of the article.
Keywords: Provide 6 to 8 keywords in alphabetical
order.
Text Organization: The main text should begin
on a separate page and should be divided into title page,
abstract and the main text. The text may be subdivided further
according to the areas to be discussed, which should be followed
by the Acknowledgement, List of Abbreviations, Conflict of
Interest (if any) and Reference sections. For Research Articles/Letters
the manuscript should begin with the title page and abstract
followed by the main text, which must be structured into separate
sections as Introduction, Materials and Methods, Results,
Discussion, and Conclusion, Acknowledgements, List of Abbreviations,
Conflict of Interest (if any) and References. If your research
article reports the results of a controlled health care intervention
such as a Drug Clinical Trial Studies/Case Report, list your
trial registry, along with the unique identifying number.
For Review, the manuscript should mention any previous important
recent and old reviews in the field and contain a comprehensive
discussion starting with the general background of the field.
It should then go on to discuss the salient features of recent
developments. The authors should avoid presenting material
which has already been published in a previous review. The
authors are advised to present and discuss their observations
in brief. The manuscript style must be uniform throughout
the text and 10 pt Times New Roman fonts should be used. The
full term for an abbreviation should precede its first appearance
in the text unless it is a standard unit of measurement. The
reference numbers should be given in square brackets in the
text. Italics should be used for Binomial names of organisms
(Genus and Species), for emphasis and for unfamiliar words
or phrases. Non-assimilated words from Latin or other languages
should also be italicized e.g. per se, et al. etc.
Trial registration: There should
be no space between the letters and numbers of your trial
registration number. All drug clinical trial studies, regardless
of when they were completed, and secondary analyses of original
drug clinical trial studies must be registered before submission
of a manuscript based on the trial. Studies designed for other
purposes, such as to study pharmacokinetics or major toxicity
(e.g., phase 1 trials), are exempt. Trial registry name, registration
identification number, and the URL for the registry should
be included at the end of abstract and also in the space provided
on the online manuscript submission form.
Authors will submit the Trial Protocols along with their manuscript.
The CONSORT (Consolidated Standards of Reporting Trials)
Checklist
and Flowchart is also required when submitting
the results of randomized control trials (RCTs).
Ethical Approval of Studies and Informed Consent:
For human or animal experimental investigations, it is a prerequisite
to provide a formal review and approval, or review and waiver,
by an appropriate institutional review board or ethics committee
and should be documented in your paper. For investigations
undertaken on human subjects, state in the Methods section
the manner in which the informed consent was obtained from
the study participants (i.e., oral or written), where there
is an unavoidable risk of breach of privacy e.g., in a clinical
photograph or in case details- the patient's written consent
or that of the next of kin, to publication must be obtained.
We will ask you to send a signed consent form before publication.
Consent must be obtained for all Case Reports and Drug Clinical
Trial Studies.
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting
changes and get corrupted or lost during preparation of manuscript
for publication. To ensure that all special characters used
are embedded in the text, these special characters should
be inserted as a symbol but should not be a result of any
format styling (Symbol font face) otherwise they will be lost
during conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design. Chemical
equations, chemical names, mathematical usage, unit of measurements,
chemical and physical quantity & units must conform
to SI and Chemical Abstracts or IUPAC.
All kinds of measurements should be reported only in International
System of Units (SI).
List of Abbreviations: If abbreviations
are used in the text either they should be defined in the
text where first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions
to the work being reported should be clearly acknowledged,
as should any potential conflict of interest.
Acknowledgements: Please acknowledge
anyone (individual/company/institution) who has contributed
to the study by making substantial contributions to conception,
design, acquisition of data, or analysis and interpretation
of data, or who was involved in drafting the manuscript or
revising it critically for important intellectual content.
Please list the source(s) of funding for the study, for each
author, and for the manuscript preparation in the acknowledgements
section.
This journal complies with the International Committee of
Medical Journal Editors' Uniform Requirements for Manuscripts
Submitted to Biomedical Journals http://www.icmje.org
and the FDA's Good Reprint Practices for the Distribution
of Medical Journal Articles and Medical or Scientific Reference
Publications on Unapproved New Uses of Approved Drugs and
Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html
Protection of Human Subjects and Animals in Research:
When reporting experiments involving human subjects, authors
should indicate whether the procedures followed were in accordance
with the ethical standards of the responsible committee on
human experimentation (institutional and national) and with
the Helsinki Declaration of 1975, as revised in 2000.
For research involving animals, authors should indicate whether
the procedures followed were in accordance with the standards
set forth in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Science, National
Academy Press, Washington, D.C.).
References: References must be listed in
the Vancouver Style only. All references should be numbered
sequentially [in square brackets] in the text and listed in
the same numerical order in the reference section. The reference
numbers must be finalized and the bibliography must be fully
formatted before submission.
See below few examples of references listed in the correct
Vancouver Style:
Typical Paper Reference:
[1] Boehm M, Nabel EG. Angiotensin-converting enzyme 2-a new
cardiac regulator. N Engl J Med 2002; 347: 1795-7.
[2] SoRelle R. Long reach of the N-terminal of B-type natriuretic
peptide. Circulation 2002; 106: 9059-63.
Typical Chapter Reference:
[3] Stevenson WG, Friedman PL. In: Hennekens CH, Ed. Clinical
trials in cardiovascular disease. Philadelphia, WB Saunders
Co. 1999; 217-30.
Book Reference:
[4] Crabtree RH. The Organometallic Chemistry of the Transition
Metals. 3rd ed. Wiley &
Sons: New York 2001.
Book Chapter Reference:
[5] Wheeler DMS, Wheeler MM. In: Studies in Natural Products
Chemistry; Atta-ur-Rahman, Ed. Elsevier Science B. V: Amsterdam
1994; 14: pp. 3-46.
Conference Proceedings:
[6] Bengtsson S, Solheim BG. Enforcement of data protection,
privacy and security in medical informatics. In: Lun KC, Degoulet
P, Piemme TE, Rienhoff O, Eds. MEDINFO 92. Proceedings of
the 7th World Congress on Medical Informatics; 1992 Sep 6-10;
Geneva, Switzerland. Amsterdam: North-Holland 1992; pp. 1561-5.
[7] Kimura J, Shibasaki H, Eds. Recent advances in clinical
neurophysiology. Proceedings of the 10th International Congress
of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto,
Japan. Amsterdam: Elsevier 1996.
URL(WebPage):
[8] National Library of Medicine. Specialized Information
Services: Toxicology and Environmental Health. http://sis.nlm.nih.gov/Tox/ToxMain.html
(Accessed May 23, 2004).
Patent:
[9] Hoch JA, Huang S. Screening methods for the identification
of novel antibiotics. US Patent 6,043,045, March 28, 2000.
Thesis:
[10] Mackel H. Capturing the Spectra of Silicon
Solar Cells. PhD Thesis, The Australian National University:
Canberra, December 2004.
E-citations:
[11] Citations for articles/material published exclusively
online or in open access (free-to-view) , must contain the
exact Web addresses (URLs) at the end of the reference(s),
except those posted on an author’s Web site unless editorially
essential, e.g. ‘Reference: Available from: URL’.
Some important points to remember:
*All references must be complete and accurate.
*If the number of authors exceeds six then et al will be used
after three names (the term “et al.”
should be in italics).
*Online citations should include the date of access.
*Journal abbreviations should follow the Index Medicus/MEDLINE.
* Take special care of the punctuation convention as described
in the above-mentioned examples.
*Superscript in the in-text citations and reference section
should be avoided.
* Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
* The authors are encouraged to use a recent version of EndNote
(version 5 and above) or Reference Manager (version 10) when
formatting their reference list, as this allows references
to be automatically extracted.
Appendices: In case there is a need to present
lengthy, but essential methodological details, use appendices,
which can be a part of the article. An appendix must not exceed
three pages (Times New Roman, 12 point fonts, 900 max. words
per page). The information should be provided in a condensed
form, ruling out the need of full sentences. A single appendix
should be titled APPENDIX, while more than one can be titled
APPENDIX A, APPENDIX B, and so on.
Figures/Illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Current
Bioinformatics. If the figures are found to
be sub-standard, then the manuscripts will be rejected/ and
the authors offered the option of figure improvement professionally
by Eureka
Science.
The costs for such improvement will be charged to the authors.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution:
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with colour mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally a continuous tone
photograph and contains no text, the preferred file format
is TIFF, with colour mode being or RGB or Grayscale, in a
resolution of 300 dpi.
For Combination image type, which is generally an image containing
halftone in addition to text or line art elements, the preferred
file format is TIFF, with colour mode being or RGB or Grayscale,
in a resolution of 500-900 dpi.
Formats
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos or
images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Sciencedoes not process figures submitted in GIF format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format. However, in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include GraphicConverter
on the Macintosh, PaintShop Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted
to EPS, since this will result in a much larger file size
than the equivalent JPEG, TIFF, PNG or BMP, with no increase
in quality. EPS should only be used for images produced by
vector-drawing applications such as Adobe Illustrator or CorelDraw.
Most vector-drawing applications can be saved in, or exported
as, EPS format. In case the images have been originally prepared
in an Office application, such as Word or PowerPoint, then
the original Office files should be directly uploaded to the
site, instead of being converted to JPEG or another format
that may be of low quality.
Color Figures/Illustrations:
• The cost for each individual page of color figures/plates/illustrations
is US$ 920.
• Color figures should be supplied in CMYK not RGB colors.
Chemical Structures:
Chemical structures must be prepared in ChemDraw/CDX and provided
as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4 pt (0.500cm,
0.2in)
Bold width 2.0
pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times
New Roman
Size 8
pt
Under the Preference Choose:
Units points
Tolerances 3
pixels
Under Page Setup Use:
Paper US
letter
Scale
100%
Tables:
*Data Tables should be submitted in Microsoft Word table format.
* Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
* Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
* Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
* Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
* Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
* If a reference is cited in both the table and text, please
insert a lettered footnote in the table to refer to the numbered
reference in the text.
* Tabular data provided as additional files can be submitted
as an Excel spreadsheet.
Supportive/Supplementary Material:
We do encourage to append supportive material, for example
a PowerPoint file containing a talk about the study, a PowerPoint
file containing additional screenshots, a Word, RTF, or PDF
document showing the original instrument(s) used, a video,
or the original data (SAS/SPSS files, Excel files, Access
Db files etc.) provided it is inevitable or endorsed by the
journal's Editor.
Any additional files will be linked into
the final published article in the form supplied by the author,
but will not be displayed within the paper. They will be made
available in exactly the same form as originally provided
only on our Web site. Please also make sure that each additional
file is a single table, figure or movie (please do not upload
linked worksheets or PDF files larger than one sheet). Supportive/
Supplementary material must be provided in a single zipped
file not larger than 4 MB.
Authors must clearly indicate if these files
are not for publication but meant for the reviewers'/editors'
perusal only.
Trial registration: There should
be no space between the letters and numbers of your trial
registration number. All drug clinical trial studies, regardless
of when they were completed, and secondary analyses of original
drug clinical trial studies must be registered before submission
of a manuscript based on the trial. Studies designed for other
purposes, such as to study pharmacokinetics or major toxicity
(e.g., phase 1 trials), are exempt. Trial registry name, registration
identification number, and the URL for the registry should
be included at the end of abstract and also in the space provided
on the online manuscript submission form.
Authors will submit the Trial Protocols along with their manuscript.
The CONSORT (Consolidated Standards of Reporting Trials)
Checklist
and Flowchart is also required when submitting
the results of randomized control trials (RCTs).
Ethical Approval of Studies and Informed Consent:
For human or animal experimental investigations, it is a prerequisite
to provide a formal review and approval, or review and waiver,
by an appropriate institutional review board or ethics committee
and should be documented in your paper. For investigations
undertaken on human subjects, state in the Methods section
the manner in which the informed consent was obtained from
the study participants (i.e., oral or written), where there
is an unavoidable risk of breach of privacy e.g., in a clinical
photograph or in case details- the patient’s written
consent or that of the next of kin, to publication must be
obtained. We will ask you to send a signed consent form before
publication. Consent must be obtained for all Case Reports
and Drug Clinical Trial Studies.
PERMISSION FOR REPRODUCTION: Published/reproduced
material should not be included unless you have obtained written
permission from the copyright holder, which should be forwarded
to the Editorial Office in case of acceptance of your article
for publication.
For obtaining permission for reproducing
any material published in an article by Bentham Science Publishers,
please fill in the request FORM
and send to cbio@benthamscience.org
for consideration.
AUTHORS AND INSTITUTIONAL AFFILIATIONS: The
author will be required to provide their full names, the institutional
affiliations and the location, with an asterisk in front of
the name of the principal/corresponding author. The corresponding
author(s) should be designated and their complete address,
business telephone and fax numbers and e-mail address must
be stated to receive correspondence and galley proofs.
PAGE CHARGES: No page charges will be levied
to authors for the publication of their article.
LANGUAGE AND EDITING: Manuscripts submitted
containing many English typographical errors will not be published.
Manuscripts which are accepted for publication on condition
that the written English submitted is corrected, will be sent
a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
언어 및 편집: 영문 오타가 많은 원고는 출판되지 않을 것입니다. 영문 오타를 없애겠다는 조건으로 받은 원고는 영어 편집 전문회사인 유럽 공동 기술개발 기구로부터 가격 견적서가 보내 질 것입니다. 영어 작문에 어려움이 있는 비영어권 국가의 저자들은 원고를 학술지에 제출하기 전에 영어 편집회사와 접촉할 것을 권합니다. 영어 편집 견적서를 받기 위해서 교정될 원고의 단어수를 적은 메일을 유럽 공동 기술개발 기구 메일인 info@eureka-science.com로 보내시기 바랍니다.
语言和编辑: 含有很多英文印刷错误的提交稿将不予发表。接受发表的稿件其英文写作应是正确的；专业的语言编辑公司（尤里卡科学），可对稿件的英文润色提供报价。建议非英语国家、且英文写作欠佳的作者在投稿前先与语言编辑公司联系。请与尤里卡科学联系 info@eureka-science.com
EDITION ET LANGUE: Les manuscrits soumis avec plusieurs erreurs typographiques en Anglais ne seront pas publiés en l’état. Les manuscrits sont acceptés pour publication à la condition que l'anglais utilisé soit corrigé après la soumission et seront envoyés pour examen à Eureka Science, une société d'édition de langue professionnelle. Les auteurs en provenance de pays où la langue est différente de l'anglais et qui ont de médiocres compétences en anglais écrit, sont priés de contacter la société d'édition de langue avant de soumettre leur manuscrit à la revue. Merci de contacter Eureka Science à info@eureka-science.com pour un devis en indiquant le nombre total de mot de l’article à éditer.
PROOF CORRECTIONS: Authors will receive page
proofs of their accepted paper before publications. To avoid
delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours.
Major changes are not acceptable at the proof stage. If unable
to send corrections within 48 hours due to
some reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named (corresponding)
author will receive electronically five free e-prints. Printed
reprints and e-prints may be ordered from the Publisher prior
to publication of the article. First named authors may also
order a personal online subscription of the journal at 50%
off the normal subscription rate by contacting the subscription
department at e-mail: subscriptions@bentham.org.
OPEN ACCESS PLUS: Accepted articles can be
published online for free open access for all to view. Open
access publishing provides the maximum dissemination of the
article to the largest audience. Authors must pay for this
service. All corresponding authors will be asked to indicate
whether or not they wish to pay to have their paper made freely
available on publication. If authors do not select the Open
Access option, then their article will be published with standard
subscription-based access at no charge.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 2,200 per
published article which allows indefinite free-to-view online
publication with Bentham Science.
All Editors, Board Members and those authors who have contributed
more than two articles in Bentham Science publications are
entitled to a 40% discount on open access
plus fees.
For more information please contact us at e-mail: openaccess@benthamscience.org.
FEATURED ARTICLE: Authors may opt to publicize
their article(s) published with Bentham Science by highlighting
their title(s) both at the journal's Homepage and the issue
Contents page at a cost of US$ 300.
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately subjected
to editorial scrutiny, usually in consultation with members
of the journal Editorial Advisory Board and outside independent
reviewers. Every effort will be made to peer review submitted
papers quickly. Papers which are delayed by authors in revision
for more than 30 days will have to be re-submitted as a new
submission. Papers accepted for publication are typeset and
proofs are dispatched to authors for any corrections prior
to final publication.
QUICK TRACK Publication: For this journal
an optional fast publication fee-based service called QUICK
TRACK is available to authors for their submitted manuscripts.
Authors who opt for this fee-based service do not have to
pay any additional charges for the improvement of figures
(if required).
QUICK TRACK allows online publication within 2 weeks of receipt
of the final approved galley proofs from the authors. Similarly
the manuscript can be published in the next forthcoming PRINT
issue of the journal. The total publication time, from date
of first receipt of manuscript to its online publication is
10 weeks, subject to its acceptance by the referees and modification
(if any) by the authors within one week.
Corresponding authors who opt for QUICK TRACKS will receive
25 free e-reprint tokens for their manuscripts.
Authors who have availed QUICK TRACK services in a BSP journal will be entitled for an exclusive 30% discount if they again wish to avail the same services in any Bentham journal.
For more information please contact the Editorial Office by
e-mail at cbio@benthamscience.org.
COPYRIGHT: Authors who publish in Bentham Science
print & online journals will transfer copyright
to their work to Bentham Science Publishers. Submission
of a manuscript to the respective journals implies that all
authors have read and agreed to the content of the Covering
Letter or the Terms and Conditions. It is a condition
of publication that manuscripts submitted to this journal
have not been published and will not be simultaneously submitted
or published elsewhere. Plagiarism is strictly forbidden,
and by submitting the article for publication the authors
agree that the publishers have the legal right to take appropriate
action against the authors, if plagiarism or fabricated information
is discovered. By submitting a manuscript the authors agree
that the copyright of their article is transferred to the
publishers if and when the article is accepted for publication.
Once submitted to the journal, the author will not withdraw
their manuscript at any stage prior to publication.
Plagiarism Prevention: Bentham
Science Publisher uses the iThenticate software to detect
instances of overlapping and similar text in submitted manuscripts.
iThenticate software checks content uploaded by a journal
editorial office against a database of periodicals, the Internet,
and a comprehensive article database. It generates a similarity
report, including the percentage overlap between the uploaded
article and published material. Any instances of content overlap
are treated according to a journal's peer review integrity
statement and the policies recommended by the editorial Committee.
You are assured that the publisher, where you are submitting
your manuscript, is committed to actively combating plagiarism
and publishing original research.
E-Pub Ahead of Schedule: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub
Ahead of Schedule.
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors and authors
and their respective employees are not responsible or liable
for the use of any such inaccurate or misleading data, opinion
or information contained of articles in the E-Pub Ahead-of-Schedule. |
